Home
About
FAQ
History (3)
Development of an upper extremity transplant program.
Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor.
Tildrakizumab: A Review of Phase II and III Clinical Trials.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development of an upper extremity transplant program.
Ravindra KV, Gorantla VS. Development of an upper extremity transplant program. Hand Clin. 2011 Nov; 27(4):531-8, x.
View in:
PubMed
subject areas
Humans
Organ Transplantation
Patient Care Team
Program Development
Public Relations
Surgery Department, Hospital
Upper Extremity
authors with profiles
Vijay S. Gorantla MD, PhD